Tessera Therapeutics (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- April 19, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $300,000,000
Company Info
- Founding Year
- 2018
- Founders
- Geoffrey von Maltzahn
- Company Description
- Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.
- Market
- Genetic Medicines
- Location
- Cambridge, MA, USA
- Coinvestors
- Abu Dhabi Investment Authority, Alaska Permanent Fund, Altitude Life Science Ventures, Artis Ventures, Cormorant Asset Management, Flagship Pioneering, Hanwha Impact Partners, Longevity Vision Fund, March Capital Partners, SALT Fund, SoftBank Vision Fund 2, T. Rowe Price Associates